The Pharma Manufacturing Editorial Advisory Board is a group of distinguished individuals assembled to assist our publication in fulfilling its editorial mission to provide professionals the tools they need to deliver authentic innovation in today's pharma environment, presented in a way that is straightforward and unpretentious.
NEWS
•Pharmaceutical Manufacturing Announces Updated Editorial Advisory Board
•The Good, the Bad & the Donald: CPhI Worldwide's 2017 Pharma Predictions
BOARD MEMBERS
Bikash Chatterjee, President, pharmatech associates
Emil Ciurczak, President, Doramaxx Consulting
Robert Dream, Managing Director, HDR Company
Barry Holtz, Chief Science Officer, Phylloceuticals
Eric Langer, President, BioPlan Associates
Ivan Lugo, Executive Director, INDUNIV
Girish Malhotra, President, EPCOT International
Rich Myer, Director of Business Development, Avara Pharmaceutical Services
Gary Ritchie, President, GER COMPLIANCE
Mike Tousey, SVP Process Development, ImmunityBio
CONTENT FROM BOARD MEMBERS
Bikash Chatterjee
Serialization and the Drug Quality & Security Act
Product Focus: Process Analytical Technologies
Henry Ford Had It Right
From ‘I Think I Can’ to ‘I Knew I Could’
Wish List, Predictions for 2017
Pros and Cons of Biosimilars
Robert Dream
Biopharma's Flexible Imperative
Barry Holtz
Growing the biologic drug supply
Planting the Seed for Speed
Plant Transient Technology Expedites Scale-Up
Eric Langer
Biopharma Market: An Inside Look
Biopharma CMO Consolidation: Opportunity or Obstacle?
Downstream Gears Up
Ivan Lugo
Battered but Unbroken
Girish Malhotra
Keeping Innovation in Our Hands
Financial Justification in Pharma
Bold Steps Needed to Alleviate Drug Shortages and Price Hikes?
Pharma’s Landscape is Going to Look a Lot Different in 2026
How to Justify Innovation and QbD in Manufacturing